Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

The Journal of Prevention of Alzheimer s Disease(2022)10.14283/jpad.2022.30Source: DataRank Database

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease is a research paper published in The Journal of Prevention of Alzheimer s Disease (2022). On theSindex it has a DataRank of 0. It has been cited 1,336 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1,336 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 129.41)OA: goldTopics (32)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Paul Aisen,Frederik Barkhof ORCID,Spyros Chalkias ORCID,Tianle Chen ORCID,Sarah Cohen ORCID

Live enrichment

PubMed:35542991 OpenAlex:https://openalex.org/W4225741213

FWCI

129.41

Citation Percentile

1.0%

Influential Citations

Citation Trend

2012

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.14283/jpad.2022.30.pdf

HYBRIDhttps://link.springer.com/content/pdf/10.14283/jpad.2022.30.pdf

publisherhttps://link.springer.com/content/pdf/10.14283/jpad.2022.30.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2274580724003327?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2274580724003327?httpAccept=text/plain

Fields of Study

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchMedicinal Plants and NeuroprotectionMedicineAlzheimer DiseaseAmyloid beta-PeptidesAntibodies, Monoclonal, HumanizedBiomarkersHumans

MeSH Terms

Alzheimer DiseaseHumansBiomarkersAmyloid beta-PeptidesAntibodies, Monoclonal, Humanized

Keywords

MedicinePlaceboClinical endpointDementiaDiseaseAlzheimer's diseaseInternal medicineClinical trialBiomarkerClinical Dementia RatingCognitionRandomized controlled trialOncologyPathologyPsychiatryAmyloid betaAlzheimer’s diseaseAducanumab

Additional file 1 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574274.v1figshare

Additional file 1 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574274figshare

Additional file 2 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574277.v1figshare

Additional file 2 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574277figshare

Additional file 3 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574280.v1figshare

Additional file 3 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574280figshare

Additional file 4 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574283.v1figshare

Additional file 4 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574283figshare

Additional file 5 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574286.v1figshare

Additional file 5 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574286figshare

Additional file 6 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574289.v1figshare

Additional file 6 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574289figshare

Additional file 7 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574292.v1figshare

Additional file 7 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574292figshare

Additional file 8 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574295.v1figshare

Additional file 8 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574295figshare

Additional file 9 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574298.v1figshare

Additional file 9 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574298figshare

Additional file 10 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574301.v1figshare

Additional file 10 of Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics

10.6084/m9.figshare.26574301figshare